Inventor
JANKOWSKI ORION D
US20 patents
⚠️ This page may combine multiple inventors who share the name “JANKOWSKI ORION D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EDISON PHARMACEUTICALS INC
5 patentsUS7968746B2Jun 28, 2011
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
EDISON PHARMACEUTICALS INC46 citations97
US9169196B2Oct 27, 2015
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
EDISON PHARMACEUTICALS INC11 citations92
US9073873B2Jul 7, 2015
2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
EDISON PHARMACEUTICALS INC4 citations72
US9090576B2Jul 28, 2015
2-substituted-p-quinone derivatives for treatment of oxidative stress diseases
EDISON PHARMACEUTICALS INC3 citations59
US9546132B2Jan 17, 2017
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
EDISON PHARMACEUTICALS INC0 citations51
BIOELECTRON TECH CORP
3 patentsUS9932286B2Apr 3, 2018
Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
BIOELECTRON TECH CORP3 citations72
US10071978B2Sep 11, 2018
Process for the production of alpha-tocotrienol and derivatives
BIOELECTRON TECH CORP3 citations67
US10167251B2Jan 1, 2019
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
BIOELECTRON TECH CORP0 citations51
PTC THERAPEUTICS INC
3 patentsUS11840497B2Dec 12, 2023
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
PTC THERAPEUTICS INC0 citations62
US11312697B2Apr 26, 2022
Process for the production of alpha-tocotrienol and derivatives
PTC THERAPEUTICS INC0 citations62
US10968166B2Apr 6, 2021
4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
PTC THERAPEUTICS INC0 citations62